BRPI0700767B8 - composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo - Google Patents

composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Info

Publication number
BRPI0700767B8
BRPI0700767B8 BRPI0700767A BRPI0700767A BRPI0700767B8 BR PI0700767 B8 BRPI0700767 B8 BR PI0700767B8 BR PI0700767 A BRPI0700767 A BR PI0700767A BR PI0700767 A BRPI0700767 A BR PI0700767A BR PI0700767 B8 BRPI0700767 B8 BR PI0700767B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical
compounds
vitiligo
treatment
obtaining
Prior art date
Application number
BRPI0700767A
Other languages
English (en)
Inventor
Ferreira Queiroz Emerson
Original Assignee
Ache Laboratorios Farmaceuticos Sa
Lara De Campos Siaulys
Plantarium Comercio De Produtos Cosmeticos E Farm E Manipulacao De Formulas Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ache Laboratorios Farmaceuticos Sa, Lara De Campos Siaulys, Plantarium Comercio De Produtos Cosmeticos E Farm E Manipulacao De Formulas Ltda filed Critical Ache Laboratorios Farmaceuticos Sa
Priority to BRPI0700767A priority Critical patent/BRPI0700767B8/pt
Priority to CA2678407A priority patent/CA2678407C/en
Priority to DK07815757T priority patent/DK2117533T3/en
Priority to US12/527,242 priority patent/US20100028400A1/en
Priority to PT07815757T priority patent/PT2117533E/pt
Priority to SI200731619T priority patent/SI2117533T1/sl
Priority to PCT/BR2007/000316 priority patent/WO2008098325A1/en
Priority to PL07815757T priority patent/PL2117533T3/pl
Priority to EP07815757.5A priority patent/EP2117533B1/en
Priority to ES07815757.5T priority patent/ES2531759T3/es
Priority to JP2009549340A priority patent/JP5443174B2/ja
Priority to MX2009008799A priority patent/MX2009008799A/es
Priority to UY30920A priority patent/UY30920A1/es
Priority to ARP080100649A priority patent/AR065365A1/es
Priority to CL200800484A priority patent/CL2008000484A1/es
Publication of BRPI0700767A publication Critical patent/BRPI0700767A/pt
Priority to CO09098715A priority patent/CO6220946A2/es
Priority to US13/919,474 priority patent/US20130287868A1/en
Priority to US15/815,964 priority patent/US10813970B2/en
Priority to US15/816,001 priority patent/US10813971B2/en
Priority to US16/125,034 priority patent/US20190134136A1/en
Publication of BRPI0700767B1 publication Critical patent/BRPI0700767B1/pt
Publication of BRPI0700767B8 publication Critical patent/BRPI0700767B8/pt
Priority to US17/478,604 priority patent/US12514896B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

composiçâo farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo. a presente invenção refere-se, de forma geral, a um processo para obtenção de um composto e um produto farmacêutico padronizado a partir uma ou mais partes de plantas do gênero stachytarpheta (família verbenaceae), assim como raízes, caules, cascas ou folhas das plantas em forma de extratos ou frações enriquecidas ou compostos puros isolados ou obtidos por síntese, usados isoladamente ou em mistura com outros produtos naturais ou sintéticos, em diferentes proporções, para integrar composições farmacêuticas a serem utilizadas por vias adequadas (tópica ou oral) em particular nas apresentações em forma de comprimidos, cápsulas, tinturas, emulsões, a/o e o/a (cremes e géis), lipossomas, microcápsulas, nanopartículas, aerossóis, pastas e. similares, assim como formulações para implantes de liberação lenta, utilizadas para o tratamento do vitiligo.
BRPI0700767A 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo BRPI0700767B8 (pt)

Priority Applications (21)

Application Number Priority Date Filing Date Title
BRPI0700767A BRPI0700767B8 (pt) 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
ES07815757.5T ES2531759T3 (es) 2007-02-15 2007-11-14 Composición farmacéutica en base a especies de Stachytarpheta, un proceso para obtener la misma y su uso para tratar el vitíligo
MX2009008799A MX2009008799A (es) 2007-02-15 2007-11-14 Composicion farmaceutica a base de stachytarpheta sp., un proceso para obtener la misma y su uso para tratar vitiligo.
US12/527,242 US20100028400A1 (en) 2007-02-15 2007-11-14 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
PT07815757T PT2117533E (pt) 2007-02-15 2007-11-14 Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo
SI200731619T SI2117533T1 (sl) 2007-02-15 2007-11-14 Farmacevtski sestavek na osnovi stachytarpheta sp., postopek za pridobivanje le-tega, in njegova uporaba za zdravljenje vitiliga
PCT/BR2007/000316 WO2008098325A1 (en) 2007-02-15 2007-11-14 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
PL07815757T PL2117533T3 (pl) 2007-02-15 2007-11-14 Kompozycja farmaceutyczna na bazie stachytarpheta sp., proces jej otrzymywania oraz jej zastosowanie do leczenia bielactwa
EP07815757.5A EP2117533B1 (en) 2007-02-15 2007-11-14 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
DK07815757T DK2117533T3 (en) 2007-02-15 2007-11-14 A pharmaceutical composition on the basis of stachytarpheta SP., Process for obtaining them and their use for the treatment of vitiligo
JP2009549340A JP5443174B2 (ja) 2007-02-15 2007-11-14 スタキタルフェタ種（Ｓｔａｃｈｙｔａｒｐｈｅｔａ ｓｐ．）に基づく医薬組成物、その取得のための方法及び白斑症を処置するためのその使用
CA2678407A CA2678407C (en) 2007-02-15 2007-11-14 A pharmaceutical composition comprising extracts of stachytarpheta sp., a process of obtaining the same and its use for treating vitiligo
UY30920A UY30920A1 (es) 2007-02-15 2008-02-14 Composicion farmaceutica, producto farmaceutico, proceso para obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo
ARP080100649A AR065365A1 (es) 2007-02-15 2008-02-15 Composicion farmaceutica, producto farmaceutico, proceso para la obtencion de compuestos farmaceuticos y uso de dichos compuestos para el tratamiento del vitiligo
CL200800484A CL2008000484A1 (es) 2007-02-15 2008-02-15 Composicion farmacologica que comprende compuestos seleccionados de iridoides, flavonoides y derivados glicosilados con etil- y fenilpropano, obtenidos de plantas del genero stachytarpheta; proceso para la obtencion de los compuestos farmacologicos;
CO09098715A CO6220946A2 (es) 2007-02-15 2009-09-14 Composicion farmaceutica con base en stachytarpheta sp un proceso para obtener la misma y su uso para tratar el vitiligio
US13/919,474 US20130287868A1 (en) 2007-02-15 2013-06-17 Pharmaceutical composition on the basis of Stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
US15/815,964 US10813970B2 (en) 2007-02-15 2017-11-17 Pharmaceutical composition on the basis of Stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
US15/816,001 US10813971B2 (en) 2007-02-15 2017-11-17 Pharmaceutical composition on the basis of Stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
US16/125,034 US20190134136A1 (en) 2007-02-15 2018-09-07 Pharmaceutical Composition on the Basis of Stachytarpheta SP., a Process for obtaining the same and its use for Treating Vitiligo
US17/478,604 US12514896B2 (en) 2007-02-15 2021-09-17 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700767A BRPI0700767B8 (pt) 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Publications (3)

Publication Number Publication Date
BRPI0700767A BRPI0700767A (pt) 2008-09-30
BRPI0700767B1 BRPI0700767B1 (pt) 2020-09-15
BRPI0700767B8 true BRPI0700767B8 (pt) 2021-05-25

Family

ID=39689569

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700767A BRPI0700767B8 (pt) 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Country Status (16)

Country Link
US (6) US20100028400A1 (pt)
EP (1) EP2117533B1 (pt)
JP (1) JP5443174B2 (pt)
AR (1) AR065365A1 (pt)
BR (1) BRPI0700767B8 (pt)
CA (1) CA2678407C (pt)
CL (1) CL2008000484A1 (pt)
CO (1) CO6220946A2 (pt)
DK (1) DK2117533T3 (pt)
ES (1) ES2531759T3 (pt)
MX (1) MX2009008799A (pt)
PL (1) PL2117533T3 (pt)
PT (1) PT2117533E (pt)
SI (1) SI2117533T1 (pt)
UY (1) UY30920A1 (pt)
WO (1) WO2008098325A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0700767B8 (pt) 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
BR102017003318A2 (pt) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5174253A (ja) 1974-12-24 1976-06-28 Sharp Kk Teidenatsusochi
JP3627068B2 (ja) * 1995-03-29 2005-03-09 日本メナード化粧品株式会社 育毛剤
IT1317732B1 (it) * 2000-01-20 2003-07-15 Giuliani Spa Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
AU2003228603A1 (en) * 2002-04-22 2003-11-10 Rtc Research And Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
FR2848117B1 (fr) 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
BRPI0406343A (pt) * 2004-11-16 2006-08-01 Marcal De Queiroz Paulo fitomedicamento para repigmentação da pele - vitiligo
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
US7399783B2 (en) * 2005-06-22 2008-07-15 The Quigley Corporation Methods for the treatment of scar tissue
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
BRPI0700767B8 (pt) 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Also Published As

Publication number Publication date
US20180071356A1 (en) 2018-03-15
JP2010518127A (ja) 2010-05-27
US20100028400A1 (en) 2010-02-04
US10813971B2 (en) 2020-10-27
CO6220946A2 (es) 2010-11-19
JP5443174B2 (ja) 2014-03-19
US20190134136A1 (en) 2019-05-09
SI2117533T1 (sl) 2015-05-29
PT2117533E (pt) 2015-03-10
AR065365A1 (es) 2009-06-03
US12514896B2 (en) 2026-01-06
MX2009008799A (es) 2009-10-28
US20130287868A1 (en) 2013-10-31
EP2117533B1 (en) 2014-12-03
EP2117533A4 (en) 2010-08-04
BRPI0700767B1 (pt) 2020-09-15
WO2008098325A1 (en) 2008-08-21
CA2678407C (en) 2021-08-31
CL2008000484A1 (es) 2008-09-05
UY30920A1 (es) 2008-09-02
EP2117533A1 (en) 2009-11-18
BRPI0700767A (pt) 2008-09-30
US20220000961A1 (en) 2022-01-06
US10813970B2 (en) 2020-10-27
US20180071357A1 (en) 2018-03-15
CA2678407A1 (en) 2008-08-21
ES2531759T3 (es) 2015-03-18
DK2117533T3 (en) 2015-03-09
PL2117533T3 (pl) 2015-06-30

Similar Documents

Publication Publication Date Title
Kumar et al. Beneficial role of antioxidant secondary metabolites from medicinal plants in maintaining oral health
Dar et al. General overview of medicinal plants: A review
Akhtar et al. A review on phytochemical and pharmacological investigations of miswak (Salvadora persica Linn)
TWI718432B (zh) 用於關節健康之組合物及方法
CR10056A (es) [(1h-indol-5-il)-heteroariloxi]-(1-aza-biciclo[3.3.1]nonanos como ligandos colinérgicos del n-achr para el tratamiento de trastornos piscóticos y neurodegenerativos
ES2683296T3 (es) Composición a base de flavonoides para uso farmacéutico, nutricional o cosmético con acción antioxidante potenciada
JO2721B1 (en) Artemisinin Derivative Dimers, Their preparation and their therapeutic application
BR112012024712A2 (pt) antagonistas do receptor vaniloide trpv1 com uma porção bicíclica
Niculescu et al. Natural compounds for preventing ear, nose, and throat-related oral infections
Telrandhe et al. Review on herbal drugs used in dental care management
Montejo et al. Hematological effects of Ipomoea batatas (camote) and Phyllanthus niruri (sampa-sampalukan) from Philippines in the ICR mice (Mus musculus)
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
BR112012026714A2 (pt) pastilhas de eritritol e isomalte
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
BRPI0921011A8 (pt) Métodos para preparar uma composição oral tópica, e, produto para cuidado oral
BRPI0700767B8 (pt) composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
BR122020000045B8 (pt) processo para obtenção de compostos farmacêuticos fitoterápicos a partir uma ou mais partes de plantas do gênero stachytarpheta
Deyrup et al. Chemical investigation of the medicinal and ornamental plant Angelonia angustifolia Benth. reveals therapeutic quantities of lupeol
Doudach et al. Cytotoxic & antioxidant activity of various extracts of Corrigiola telephiifolia Pourr
FR2915993B1 (fr) Nouveaux ligands agonistes des recepteurs pars, utilisation en medecine humaine ainsi qu'en cosmetique.
Raikwar Azadirachta Indica (Neem) in Traditional Indian Medicine: Indigenous Knowledge & Scientific Validation
Gill et al. Elaeagnus conferta: a comprehensive review
BR112012018696A2 (pt) composição farmacêutica com atividade antiobesidade compreendendo uma pré-mistura de orlistat puro e processo de preparação
BR112012009369A2 (pt) extrato vegetal padronizado, processo para preparação de extrato de plantas do gênero sclerolobium, composição cosmética, composição farmacêutica e uso do referido extrato
Sultana et al. Guava in Dentistry: A Potent Transition from Traditional to Modern Medicine in Oral Health

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: PLANTARIUM COMERCIO DE PRODUTOS COSMETICOS E FARMA

Free format text: TRANSFERIDO DE: LARA DE CAMPOS SIAULYS

B25A Requested transfer of rights approved

Owner name: ACHE LABORATORIOS FARMACEUTICOS S.A. (BR/SP)

Free format text: TRANSFERIDO DE: PLANTARIUM COMERCIO DE PRODUTOS COSMETICOS E FARMACEUTICOS E MANIPULACAO DE FORMULAS LTDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/02/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF